RxDoctor Payments DataLook up a doctor →

Kelly Xiong, NP

Nurse Practitioner · Charlotte, NCNPI 1740670702

Payments from drug & device makers

$16,196in general payments, 2019–2025

Across 977 payments — averaging $16.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$2K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Novartis$1K
  • AbbVie$931
  • UCB, Inc.$765
  • Neurelis, Inc.$756
  • plus $10K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Inspire Medical Systems, Inc.24$1,590
Teva Pharmaceuticals USA, Inc.104$1,335
Novartis80$1,118
AbbVie81$931
UCB, Inc.63$765
Neurelis, Inc.39$756
Biogen39$653
Sumitomo Pharma America, Inc.32$626
Eisai Inc.34$609
Biohaven Pharmaceuticals, Inc.46$480
Biohaven Pharmaceutical Holding Company Ltd.36$477
Lilly USA, LLC33$471
AstraZeneca(2 entities)17$408
Jazz Pharmaceuticals Inc.18$389
Supernus Pharmaceuticals, Inc.32$357
Neurocrine Biosciences, Inc.16$322
Sunovion Pharmaceuticals Inc.22$321
Pfizer22$311
SK Life Science, Inc.18$299
Impel Pharmaceuticals Inc.21$298
MDD US Operations, LLC20$278
Bristol Myers Squibb14$269
Acadia Pharmaceuticals Inc18$243
Takeda Pharmaceuticals U.S.A., Inc.13$225
Sanofi11$221
EMD Serono, Inc.12$220
Lundbeck LLC7$151
Idorsia Pharmaceuticals US Inc6$130
Johnson & Johnson7$125
Axsome Therapeutics, Inc.6$125
Livanova USA, Inc.6$112
Arbor Pharmaceuticals, Inc.5$101
Catalyst Pharmaceuticals, Inc.4$98
Insightec,inc3$94
Collegium Pharmaceutical, Inc.5$89
Argenx US, Inc.3$80
Aucta Pharmaceuticals, Inc.5$78
Ironshore Pharmaceuticals Inc.4$73
Avadel CNS Pharmaceuticals, LLC3$66
Aquestive Therapeutics, Inc.4$64
GRT US Holding, Inc.5$62
GE HealthCare3$61
Almatica Pharma LLC3$55
Biomarin Pharmaceutical Inc.2$51
E.r. Squibb & Sons, L.L.C.2$48
Avanir Pharmaceuticals, Inc.3$47
Harmony Biosciences LLC2$45
Avion Pharmaceuticals2$41
Cala Health, Inc.1$40
Banner Life Sciences, LLC2$39
Scilex Pharmaceuticals Inc.2$36
Mallinckrodt Hospital Products Inc.2$34
Acorda Therapeutics, Inc1$31
Immedica Pharma US, Inc.1$29
Vanda Pharmaceuticals Inc.1$29
Amgen1$23
Aprecia Pharmaceuticals, LLC1$22
Corium, LLC2$22
Alnylam Pharmaceuticals Inc.1$19
Kyowa Kirin, Inc.1$18

How this compares

$16,196 in reported general payments places this provider in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina →

Medicare billing

Part B allowed, 2024
$26,735
Medicare patients
179
Services billed
330

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Charlotte

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →